Filing Details

Accession Number:
0001209191-19-010406
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-14 18:16:52
Reporting Period:
2019-02-12
Accepted Time:
2019-02-14 18:16:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
860730 Hca Healthcare Inc. HCA Services-General Medical & Surgical Hospitals, Nec (8062) 273865930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216850 B Bill Rutherford One Park Plaza
Nashville TN 37203
Cfo And Evp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-12 37,500 $17.33 58,972 No 4 M Direct
Common Stock Disposition 2019-02-12 37,500 $139.65 21,472 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-02-12 18,750 $0.00 18,750 $17.33
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-02-12 18,750 $0.00 18,750 $17.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-11-02 No 4 M Direct
0 2021-11-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 40,000 Indirect By BNR LLC
Common Stock 10,000 Indirect By TJR LLC
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.27 to $139.93, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets.
  3. The option vested in three equal annual installments beginning on November 2, 2013.